Marc Thier

Dr. Marc Thier is a Researcher at the German Cancer Research Center (DKFZ) and Heidelberg University, leading the Neural Reprogramming and Clinical Translation group. His work bridges stem cell biology, direct cellular reprogramming, and clinical applications in cancer and endocrinology.

• Key Research Themes:
  • Stem Cell Engineering
  • Neural Reprogramming
  • Cancer Metastasis Mechanisms
  • Hyperparathyroidism Surgery Outcomes
• Notable Collaborations: Prof. Frank Edenhofer, Prof. Andreas Trumpp, Dr. Michael Milsom

Dr. Thier's recent publications focus on glioblastoma neuron-tumor interactions (2025), miRNA-driven reprogramming (2012), and stem cell dormancy models (2016). He has contributed to over 15 peer-reviewed studies since 2009.

His laboratory develops protocols for converting somatic cells into expandable neural progenitors and investigates cancer stem cell dynamics. Current projects include retrograde tracing in glioblastomas and longitudinal metabolic studies in post-surgical endocrinology.